Milestone Pharmaceuticals Stock Market Value
| MIST Stock | USD 1.70 0.02 1.16% |
| Symbol | Milestone |
Is there potential for Pharmaceuticals market expansion? Will Milestone introduce new products? Factors like these will boost the valuation of Milestone Pharmaceuticals. Expected growth trajectory for Milestone significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about Milestone Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Investors evaluate Milestone Pharmaceuticals using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Milestone Pharmaceuticals' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause Milestone Pharmaceuticals' market price to deviate significantly from intrinsic value.
Understanding that Milestone Pharmaceuticals' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Milestone Pharmaceuticals represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Milestone Pharmaceuticals' market price signifies the transaction level at which participants voluntarily complete trades.
Milestone Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Milestone Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Milestone Pharmaceuticals.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in Milestone Pharmaceuticals on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding Milestone Pharmaceuticals or generate 0.0% return on investment in Milestone Pharmaceuticals over 90 days. Milestone Pharmaceuticals is related to or competes with Rani Therapeutics, Molecular Partners, Applied Therapeutics, Cardiff Oncology, Elicio Therapeutics, Innate Pharma, and Corbus Pharmaceuticals. Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiov... More
Milestone Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Milestone Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Milestone Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.84 | |||
| Information Ratio | 0.008 | |||
| Maximum Drawdown | 34.31 | |||
| Value At Risk | (6.38) | |||
| Potential Upside | 6.15 |
Milestone Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Milestone Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Milestone Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Milestone Pharmaceuticals historical prices to predict the future Milestone Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0288 | |||
| Jensen Alpha | 0.0284 | |||
| Total Risk Alpha | (0.30) | |||
| Sortino Ratio | 0.0078 | |||
| Treynor Ratio | 0.0959 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Milestone Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Milestone Pharmaceuticals February 13, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0288 | |||
| Market Risk Adjusted Performance | 0.1059 | |||
| Mean Deviation | 3.29 | |||
| Semi Deviation | 4.53 | |||
| Downside Deviation | 4.84 | |||
| Coefficient Of Variation | 3960.05 | |||
| Standard Deviation | 4.68 | |||
| Variance | 21.93 | |||
| Information Ratio | 0.008 | |||
| Jensen Alpha | 0.0284 | |||
| Total Risk Alpha | (0.30) | |||
| Sortino Ratio | 0.0078 | |||
| Treynor Ratio | 0.0959 | |||
| Maximum Drawdown | 34.31 | |||
| Value At Risk | (6.38) | |||
| Potential Upside | 6.15 | |||
| Downside Variance | 23.38 | |||
| Semi Variance | 20.51 | |||
| Expected Short fall | (3.62) | |||
| Skewness | (0.24) | |||
| Kurtosis | 4.33 |
Milestone Pharmaceuticals Backtested Returns
Milestone Pharmaceuticals has Sharpe Ratio of -0.1, which conveys that the firm had a -0.1 % return per unit of risk over the last 3 months. Milestone Pharmaceuticals exposes twenty-eight different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Milestone Pharmaceuticals' Downside Deviation of 4.84, mean deviation of 3.29, and Risk Adjusted Performance of 0.0288 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 1.13, which conveys a somewhat significant risk relative to the market. Milestone Pharmaceuticals returns are very sensitive to returns on the market. As the market goes up or down, Milestone Pharmaceuticals is expected to follow. At this point, Milestone Pharmaceuticals has a negative expected return of -0.42%. Please make sure to verify Milestone Pharmaceuticals' maximum drawdown, as well as the relationship between the skewness and day typical price , to decide if Milestone Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.58 |
Modest predictability
Milestone Pharmaceuticals has modest predictability. Overlapping area represents the amount of predictability between Milestone Pharmaceuticals time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Milestone Pharmaceuticals price movement. The serial correlation of 0.58 indicates that roughly 58.0% of current Milestone Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.58 | |
| Spearman Rank Test | 0.51 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Milestone Stock Analysis
When running Milestone Pharmaceuticals' price analysis, check to measure Milestone Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Milestone Pharmaceuticals is operating at the current time. Most of Milestone Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Milestone Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Milestone Pharmaceuticals' price. Additionally, you may evaluate how the addition of Milestone Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.